Publication | Closed Access
Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial
97
Citations
16
References
2001
Year
This regimen is tolerable and results are promising. We recommend further evaluation of this regimen in a phase III trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1